NASDAQ:APYX Apyx Medical Q3 2026 Earnings Date & Estimates $2.59 +0.23 (+9.75%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$2.70 +0.11 (+4.21%) As of 10/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Apyx Medical is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. The conference call is scheduled for 8:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 5, 2026TimeBefore Market OpensConference Call8:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Apyx Medical in Q3 2026Apyx Medical is expected to post earnings of -$0.07 per share on revenue of $13.29 million. In the same quarter a year earlier Apyx Medical reported -$0.05 per share on revenue of $12.88 million. Apyx Medical last reported on August 6, 2026, posting -$0.07 per share and beating the -$0.0820 consensus estimate. Apyx Medical has beaten the consensus EPS estimate in 8 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.07Expected Revenue$13.29 millionPrior-Year EPS-$0.05Prior-Year Revenue$12.88 millionExpected Revenue Growth+3.2%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.07 (Beat by +$0.0120)Last Quarter Revenue$13.88 millionEPS Beat Rate8 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Apyx Medical Q3 2026 Earnings FAQ When does Apyx Medical report Q3 2026 earnings? Apyx Medical (NASDAQ:APYX) is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. What time is Apyx Medical's Q3 2026 earnings call? Apyx Medical's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Apyx Medical? Analysts expect Apyx Medical to post earnings of -$0.07 per share for Q3 2026. How much revenue is Apyx Medical expected to report? The consensus revenue estimate for Apyx Medical is $13.29 million for Q3 2026. Apyx Medical Earnings HeadlinesMaxim Group Initiates Coverage on Apyx Medical (NASDAQ:APYX)October 1, 2026 | americanbankingnews.comApyx Medical Corporation gibt neue klinische Studie zur Wirkung von Renuvion auf die Hautqualität bekanntSeptember 30, 2026 | de.marketscreener.comDFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's visibility into consumer bank transactions. A pilot program is reportedly already underway, with wider rollout at major banks possibly beginning this summer. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what the document says and what steps account holders might consider.October 10 at 1:00 AM | Weiss Ratings (Ad)Apyx Medical Corporation Announces New Clinical Study Demonstrating Renuvion?S Impact on Skin QualitySeptember 29, 2026 | marketscreener.comMApyx Medical pubblica i risultati dello studio sul trattamento RenuvionSeptember 29, 2026 | it.investing.comMaxim Group initiates coverage of Apyx Medical with buySeptember 29, 2026 | msn.comSee More Apyx Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Apyx Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Apyx Medical and other key companies, straight to your email. Email Address About Apyx MedicalApyx Medical (NASDAQ:APYX) (NASDAQ: APYX) is a medical technology company that develops, manufactures and markets advanced energy systems for use in surgical and aesthetic procedures. The company’s products are based primarily on its proprietary Helium Plasma technology, which combines helium gas and radiofrequency energy to deliver controlled thermal effects to soft tissue. Its principal product platform is Renuvion, a system designed for use by physicians in soft-tissue procedures. The platform includes generators, handpieces and related accessories intended to support tissue coagulation, cutting, dissection and contraction in various surgical and aesthetic applications. Apyx Medical also offers Plasma/RF products for hospital and ambulatory surgical settings. The company was formerly known as Bovie Medical Corporation and adopted the Apyx Medical name in 2018 as it focused more closely on its advanced energy technology portfolio. Apyx Medical serves customers in the United States and international markets through a combination of direct sales and distribution relationships. The company is headquartered in Clearwater, Florida, and is led by President and Chief Executive Officer Charlie Goodwin.View Apyx Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part Begins Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
